TY - JOUR
T1 - Antibody mediated activation of natural killer cells in malaria exposed pregnant women
AU - Damelang, Timon
AU - Aitken, Elizabeth H
AU - Hasang, Wina
AU - Lopez, Ester
AU - Killian, Martin
AU - Unger, Holger W
AU - Salanti, Ali
AU - Shub, Alexis
AU - McCarthy, Elizabeth
AU - Kedzierska, Katherine
AU - Lappas, Martha
AU - Kent, Stephen J
AU - Rogerson, Stephen J
AU - Chung, Amy W
PY - 2021/2/18
Y1 - 2021/2/18
N2 - Immune effector responses against Plasmodium falciparum include antibody-mediated activation of innate immune cells, which can induce Fc effector functions, including antibody-dependent cellular cytotoxicity, and the secretion of cytokines and chemokines. These effector functions are regulated by the composition of immunoglobulin G (IgG) Fc N-linked glycans. However, a role for antibody-mediated natural killer (NK) cells activation or Fc N-linked glycans in pregnant women with malaria has not yet been established. Herein, we studied the capacity of IgG antibodies from pregnant women, with placental malaria or non-placental malaria, to induce NK cell activation in response to placental malaria-associated antigens DBL2 and DBL3. Antibody-mediated NK cell activation was observed in pregnant women with malaria, but no differences were associated with susceptibility to placental malaria. Elevated anti-inflammatory glycosylation patterns of IgG antibodies were observed in pregnant women with or without malaria infection, which were not seen in healthy non-pregnant controls. This suggests that pregnancy-associated anti-inflammatory Fc N-linked glycans may dampen the antibody-mediated activation of NK cells in pregnant women with malaria infection. Overall, although anti-inflammatory glycans and antibody-dependent NK cell activation were detected in pregnant women with malaria, a definitive role for these antibody features in protecting against placental malaria remains to be proven.
AB - Immune effector responses against Plasmodium falciparum include antibody-mediated activation of innate immune cells, which can induce Fc effector functions, including antibody-dependent cellular cytotoxicity, and the secretion of cytokines and chemokines. These effector functions are regulated by the composition of immunoglobulin G (IgG) Fc N-linked glycans. However, a role for antibody-mediated natural killer (NK) cells activation or Fc N-linked glycans in pregnant women with malaria has not yet been established. Herein, we studied the capacity of IgG antibodies from pregnant women, with placental malaria or non-placental malaria, to induce NK cell activation in response to placental malaria-associated antigens DBL2 and DBL3. Antibody-mediated NK cell activation was observed in pregnant women with malaria, but no differences were associated with susceptibility to placental malaria. Elevated anti-inflammatory glycosylation patterns of IgG antibodies were observed in pregnant women with or without malaria infection, which were not seen in healthy non-pregnant controls. This suggests that pregnancy-associated anti-inflammatory Fc N-linked glycans may dampen the antibody-mediated activation of NK cells in pregnant women with malaria infection. Overall, although anti-inflammatory glycans and antibody-dependent NK cell activation were detected in pregnant women with malaria, a definitive role for these antibody features in protecting against placental malaria remains to be proven.
KW - Adult
KW - Antibodies, Protozoan/immunology
KW - Antibody-Dependent Cell Cytotoxicity/immunology
KW - Antigens, Protozoan/immunology
KW - Erythrocytes/immunology
KW - Female
KW - Glycosylation
KW - Humans
KW - Immunoglobulin Fc Fragments/immunology
KW - Immunoglobulin G/immunology
KW - Killer Cells, Natural/immunology
KW - Malaria, Falciparum/immunology
KW - Placenta/immunology
KW - Plasmodium falciparum/immunology
KW - Pregnancy
KW - Pregnancy Complications, Parasitic/immunology
KW - Pregnant Women
KW - Young Adult
UR - http://www.scopus.com/inward/record.url?scp=85101241370&partnerID=8YFLogxK
U2 - 10.1038/s41598-021-83093-4
DO - 10.1038/s41598-021-83093-4
M3 - Journal article
C2 - 33602987
SN - 2045-2322
VL - 11
SP - 4130
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 4130
ER -